På denne side bringer DANSK BIOTEK nyheder fra medlemmerne, som på denne måde får mulighed for at blive ekstra eksponeret.

Vi modtager derfor gerne pressemeddelelser og andre nyheder. Send dem til Dorte Dannemann, hjælp af denne formular.

28 Apr 2010

ALK to acquire Fornix BioSciences

ALK and Dutch-based Fornix BioSciences (”Fornix”) have today entered into an agreement to the effect that ALK proposes to acquire the Dutch activities of Fornix’ Allergy Division, Artu Biologicals (“Artu”), for a cash consideration of EUR 19.6 million (DKK 146 million) on a debt and cash free basis. The Supervisory Board and the Board of Management of Fornix have approved and recommend the transaction to the company’s shareholders.

The acquisition is subject to final approval by Fornix’ shareholders. The transaction is expected to become effective on July 1, 2010, after which Artu and ALK’s Dutch subsidiary will be fully integrated.

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or 28895854

Copyright 2010 Danskbiotek. All rights reserved.